-Ogp should work.

On Thu, Jun 11, 2009 at 10:25 AM, Ruby<[email protected]> wrote:
>
> Thanks!1
> So just to clarify, I can use -Ogp to do the glyco model + run protein
> prophet afterwards...or should it be -Og -Op (separate)?
>
> On Jun 11, 1:21 pm, David Shteynberg <[email protected]>
> wrote:
>> Hi Rebekah,
>>
>> Using -Og as an xinteract option will enable the use of the Glyco
>> model to modify the probabilities.  If you are using xinteract you
>> should not have to run PeptideProphetParser separately,  xinteract
>> will do it for you and enable all the correct options.
>>
>> -David
>>
>> On Thu, Jun 11, 2009 at 9:09 AM, Ruby<[email protected]> wrote:
>>
>> > I am a bit confused on the best manner in which to process data from
>> > an N-linked glyco capture experiment, analyzed via the orbitrap. I
>> > know how to 'highlight' those peptides with the NxS/T motif, but am
>> > hoping that there is also a way that the algorithms can somehow reward
>> > or otherwise consider the motif in the probability calculations as
>> > well.
>>
>> > What is the difference between the following options:
>> > 1) PeptideProphetParser interact.xml GLYC - which "uses peptide NxS/T
>> > motif in probability calculation"
>> > 2) -Og - which "uses N-glyc motif information in PeptideProphet"
>>
>> > It seems like either option would affect the data at the
>> > peptideprophet level, and 'reward' those peptides that contain the
>> > motif. Correct?
>>
>> > When I try option #1 by typing in "PeptideProphetParser interact.xml
>> > GLYC", I get an error: "cannot parse input file PeptideProphetParser"
>> > Help!!???
>>
>> > Thanks!
>> > Rebekah
>>
>>
> >
>

--~--~---------~--~----~------------~-------~--~----~
You received this message because you are subscribed to the Google Groups 
"spctools-discuss" group.
To post to this group, send email to [email protected]
To unsubscribe from this group, send email to 
[email protected]
For more options, visit this group at 
http://groups.google.com/group/spctools-discuss?hl=en
-~----------~----~----~----~------~----~------~--~---

Reply via email to